Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review UAAS El Din, MM Salem, DO Abdulazim Journal of advanced research 8 (5), 537-548, 2017 | 384 | 2017 |
Diabetic nephropathy: Time to withhold development and progression-A review UAAS El Din, MM Salem, DO Abdulazim Journal of advanced research 8 (4), 363-373, 2017 | 69 | 2017 |
Stop chronic kidney disease progression: Time is approaching UAAS El Din, MM Salem, DO Abdulazim World journal of nephrology 5 (3), 258, 2016 | 58 | 2016 |
Vascular calcification: When should we interfere in chronic kidney disease patients and how? UAAS El Din, MM Salem, DO Abdulazim World journal of nephrology 5 (5), 398, 2016 | 33 | 2016 |
Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients A Fayed, MM El Nokeety, AA Heikal, DO Abdulazim, MM Naguib, ... Renal failure 40 (1), 226-230, 2018 | 22 | 2018 |
Is fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review UAAS El Din, MM Salem, DO Abdulazim Journal of Advanced Research 8 (3), 271-278, 2017 | 20 | 2017 |
Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease UAAS El Din, MM Salem, DO Abdulazim nefrologia 42 (4), 390-403, 2022 | 12 | 2022 |
FGF23 and inflammation UAAS El Din, MM Salem, DO Abdulazim World journal of nephrology 6 (1), 57-58, 2017 | 12 | 2017 |
Recent advances in management of diabetic nephropathy MM Salem, DO Abdulazim Journal of Clinical & Experimental Nephrology 2 (2), 35, 2017 | 8 | 2017 |
Vitamin-D deficiency is encountered in almost all egyptian stage 3-5 chronic kidney disease patients in spite of the sunny weather US El Din, A Fayed, MM El Nokeety, DO Abdulazim, MM Salem Saudi Journal of Kidney Diseases and Transplantation 30 (6), 1389-1397, 2019 | 7 | 2019 |
Urine albumin and serum uric acid are important determinants of serum 25 hydroxyvitamin D level in pre-dialysis chronic kidney disease patients A Fayed, MM El Nokeety, AA Heikal, KM Sadek, H Hammad, ... Renal Failure 41 (1), 540-546, 2019 | 6 | 2019 |
Serum sclerostin in acute kidney injury patients A Fayed, DO Abdulazim, M Amin, S Elhadidy, HH Samir, MM Salem, ... Nefrología (English Edition) 42 (1), 50-55, 2022 | 5 | 2022 |
Impact of hepatitis virus infection on arterial calcification among incident hemodialysis patients A Fayed, A Soliman, H El Mahdy, W Hamza, DO Abdulazim, MM Salem, ... Nefrología (English Edition) 40 (3), 336-344, 2020 | 5 | 2020 |
SED UAA. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients A Fayed, NMM El, AA Heikal, DO Abdulazim, MM Naguib Renal Failure 40, 226-230, 2018 | 5 | 2018 |
Clinical significance of interferon lambda-3 (IFNλ3)/interleukin 28B (IL28B) in systemic lupus erythematosus patients FH Abdelraouf, MES Ramadan, DO Abdulazim, HM Selim The Egyptian Rheumatologist 44 (2), 121-125, 2022 | 3 | 2022 |
Serum urate lowering therapy using allopurinol improves serum 25 hydroxy vitamin d in stage 3-5 CKD patients: A pilot study AA Mohammed, MA Marie, DO Abdulazim, M Hassan, O Shaker, ... Nephron 145 (2), 133-136, 2021 | 3 | 2021 |
Vitamin D deficiency: an unrecognized cause of flank pain DO Abdulazim, MM Salem, M Hassan, A Abdo, E Rashad, ... Journal of Bone and Mineral Metabolism 36 (5), 605-608, 2018 | 3 | 2018 |
Pattern of non-infectious uveitis and visual outcome in a tertiary care university-based hospital: A multidisciplinary approach AH Eldesouky, MR Fadel, SA Husein, DO Abdulazim The Egyptian Rheumatologist 45 (2), 165-169, 2023 | 2 | 2023 |
Time to prevent the development of diabetic nephropathy in both type 1 and type 2 diabetic patients UA Sharaf El Din, MM Salem, DO Abdulazim J Clin Nephrol Kidney Dis 4, 1023, 2019 | 2 | 2019 |
Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study A Fayed, AA Hammad, DO Abdulazim, H Hammad, M Amin, S Elhadidy, ... Renal Failure 45 (1), 2194434, 2023 | 1 | 2023 |